Shares of Aurobindo Pharma rose as much as 2.18% in early morning trade after the company announced it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Ertapenem Injection 1 g/vial.
For more information on commodity tips
and quick free trial click here > 911 133 9000
Visit http://www.epicresearch.co
Sign up here with your email